D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Green Plains
GPRE
$1.21B
| $8.06M | 0.01% |
1,661,383
+863,316
| +108% | +$6.18M |
|
1452
Brookfield Asset Management
BAM
$76.6B
| $8.04M | 0.01% |
+165,886
| New | +$9.04M |
|
1453
First Bancorp
FBP
$4.4B
| $8.04M | 0.01% |
419,227
+251,820
| +150% | +$4.89M |
|
1454
Invesco
IVZ
$13B
| $8.03M | 0.01% |
529,538
+437,343
| +474% | +$7.46M |
|
1455
Occidental Petroleum
OXY
$55.6B
| $8.02M | 0.01% |
162,424
-327,336
| -67% | -$16M |
|
1456
Regions Financial
RF
$26.3B
| $7.98M | 0.01% |
367,280
+67,867
| +23% | +$1.58M |
|
1457
Alpha Metallurgical Resources
AMR
$1.82B
| $7.97M | 0.01% |
63,618
+37,438
| +143% | +$6.09M |
|
|
HDSN
1458
Hudson Technologies
HDSN
$244M
| $7.97M | 0.01% |
1,291,225
-54,328
| -4% | -$319K |
|
1459
Kornit Digital
KRNT
$695M
| $7.96M | 0.01% |
417,371
-45,578
| -10% | -$1.19M |
|
|
EHAB
1460
DELISTED
Enhabit
EHAB
| $7.94M | 0.01% |
903,205
-101,010
| -10% | -$848K |
|
1461
PUT
Twilio
TWLO
$29B
| $7.92M | 0.01% |
80,900
-171,700
| -68% | -$20.3M |
|
1462
PUT
Altria Group
MO
$113B
| $7.92M | 0.01% |
131,900
-83,900
| -39% | -$4.58M |
|
1463
PUT
Ross Stores
ROST
$81B
| $7.9M | 0.01% |
61,800
+50,000
| +424% | +$7M |
|
1464
Amdocs
DOX
$5.87B
| $7.89M | 0.01% |
86,279
+5,122
| +6% | +$447K |
|
|
ECHO
1465
EchoStar
ECHO
$25B
| $7.89M | 0.01% |
308,252
-392,868
| -56% | -$10.7M |
|
1466
Viking Therapeutics
VKTX
$3.86B
| $7.88M | 0.01% |
326,294
+224,051
| +219% | +$7.08M |
|
1467
CALL
Elevance Health
ELV
$81.6B
| $7.87M | 0.01% |
+18,100
| New | +$7.27M |
|
1468
Raymond James Financial
RJF
$33.6B
| $7.87M | 0.01% |
56,639
-168,632
| -75% | -$26.2M |
|
1469
Opko Health
OPK
$993M
| $7.85M | 0.01% |
+4,731,688
| New | +$7.79M |
|
1470
Sally Beauty Holdings
SBH
$1.46B
| $7.85M | 0.01% |
869,519
-477,628
| -35% | -$4.7M |
|
1471
PUT
Harley-Davidson
HOG
$2.59B
| $7.83M | 0.01% |
310,000
+210,000
| +210% | +$5.62M |
|
1472
CALL
GitLab
GTLB
$5.7B
| $7.82M | 0.01% |
166,400
+71,500
| +75% | +$4.37M |
|
1473
Collegium Pharmaceutical
COLL
$1.17B
| $7.79M | 0.01% |
261,132
+43,319
| +20% | +$1.32M |
|
1474
PUT
Celanese
CE
$4.91B
| $7.79M | 0.01% |
137,300
+45,500
| +50% | +$2.84M |
|
1475
Replimune Group
REPL
| $7.77M | 0.01% |
796,580
-175,995
| -18% | -$2.18M |
|
Similar funds
D.E. Shaw & Co's Q1 2025 Portfolio in Review
As of Q1 2025, D.E. Shaw & Co held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- D.E. Shaw & Co's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- D.E. Shaw & Co added most to GE Vernova in Q1 2025, an estimated $686M increase.
- D.E. Shaw & Co's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- D.E. Shaw & Co opened 569 new positions and closed 704 in Q1 2025.
- D.E. Shaw & Co's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.